Description
Human Prostate Carcinoma Cells (LNCaP Clone FGC) were derived from a prostate carcinoma patient. LNCaP clone FGC was isolated in 1977 by J.S. Horoszewicz, et al., from a needle aspiration biopsy of the left supraclavicular lymph node of a 50-year-old Caucasian male (blood type B+) with a confirmed diagnosis of metastatic prostate carcinoma. LNCaP cells are sensitive to androgens unlike other prostate cancer cell lines. Cells are supplied in frozen vials with more than 5x10^5 cells/vial. Universal Full Growth Medium (TM001) is recommended to culture the cells.
Cells are prepared and manufactured in an ISO 9001:2015 certified environment and ISO 5 cleanroom.
Product Highlights:
You'll also need
What this product needs to grow and work as described.
- Cell Detachment SolutionADF001 · 50 ml$70.80
- Universal Full Growth MediumTM001 · 500 ml$315.60
Related products
For research use only. Not for diagnostic or clinical use.